Virtual Reality for Reducing Anxiety in Pediatric Orthopedic Surgery (RAGAZ)

February 17, 2026 updated by: Istituto Ortopedico Rizzoli

realtà Aumentata Generatrice di Ansia Zero

This study, titled "R.A.G.A.Z.: Virtual Reality for Reducing Anxiety and Pain in Pediatric Orthopedic Surgery," aims to see if using virtual reality (VR) can help children feel less anxious and experience less pain during minor orthopedic surgeries. The research will compare the effects of VR to the usual pre-surgery sedative medication.

**Study Hypotheses**

The researchers hypothesize that using VR will:

1. Reduce anxiety levels in children before and after surgery compared to standard sedative medication.

**Who can participate?**

  • Children aged 7 to 12 years
  • Undergoing minor orthopedic surgery lasting less than 60 minutes
  • Eligible for regional anesthesia

**Study Process**

Participants will be randomly assigned to one of two groups:

  1. VR Group: Children will use VR headsets to immerse themselves in calming virtual environments before and during the surgery.
  2. Standard Care Group: Children will receive standard sedative medication before surgery.

The study will measure:

  • Levels of anxiety before and after surgery using a specific anxiety meter (CAM-S).
  • Stress hormone levels (cortisol, adrenaline, noradrenaline) from blood samples.
  • Pain levels at different times after surgery.
  • How well children cooperate during medical procedures.
  • Satisfaction levels of children, parents, and surgeons.

The study is being conducted by IRCCS - Istituto Ortopedico Rizzoli in Bologna, Italy. It is a non-profit study funded by donations.

The goal is to find out if VR can reduce the need for sedatives, decrease anxiety and pain, and improve the overall surgical experience for children.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

**Detailed Description**

This study, titled "R.A.G.A.Z.: Virtual Reality for Reducing Anxiety and Pain in Pediatric Orthopedic Surgery," aims to evaluate the effectiveness of virtual reality (VR) in reducing perioperative anxiety and pain in children undergoing minor orthopedic surgeries. The study will compare the use of VR headsets to the traditional method of pre-surgery sedation with medication.

**Purpose of the Study**

The primary objective of this study is to determine whether VR can provide better control of anxiety in pediatric patients before and after anesthetic and surgical procedures. The study will also assess whether VR can reduce the need for sedative and pain-relief medications, thereby minimizing potential side effects and improving recovery times.

**Study Hypotheses**

The researchers hypothesize that VR will:

  1. Significantly reduce anxiety levels in children before and after surgery compared to standard sedation practices.
  2. Lower stress hormone levels (cortisol, adrenaline, noradrenaline) associated with surgical procedures.
  3. Reduce the perceived pain during and after surgery.
  4. Decrease the overall consumption of sedative and analgesic medications.
  5. Good patient compliance during medical procedures.
  6. Good satisfaction levels for patients, their parents, and healthcare providers.

**Study Design**

This is a non-profit, randomized controlled trial conducted at the IRCCS - Istituto Ortopedico Rizzoli in Bologna, Italy. The study will include 50 children aged 7 to 12 years, who are candidates for minor orthopedic surgeries lasting less than 60 minutes. Participants will be randomly assigned to one of two groups:

  1. **VR Group**: Children in this group will use VR headsets to experience calming virtual environments such as underwater scenes or peaceful gardens. The VR sessions will begin before the surgical procedure and continue through the perioperative period.
  2. **Standard Care Group**: Children in this group will receive the usual care, which includes pre-surgery sedation with midazolam, a common sedative used to reduce anxiety.

**Procedures**

  • **Anxiety Assessment**: The Children's Anxiety Meter-State (CAM-S) will be used to measure anxiety levels at multiple points: preoperatively, upon arrival at the operating room, and at 3, 6, and 24 hours postoperatively.
  • **Stress Hormone Levels**: Blood samples will be taken at the time of venipuncture to measure cortisol, adrenaline, and noradrenaline levels, which are indicators of surgical stress.
  • **Pain Assessment**: Pain levels will be evaluated using the Faces Pain Scale-Revised (FPS-R) at various postoperative intervals (3, 6, and 24 hours).
  • **Patient Compliance**: The Modified Induction Compliance Checklist (MICC) will be used to assess how well children comply with medical procedures such as venipuncture and anesthesia administration.
  • **Satisfaction Surveys**: Satisfaction levels of patients, parents, and surgeons will be recorded using a scale from 1 to 10. This will assess overall satisfaction with the VR intervention and the surgical experience.

**Expected Outcomes**

The study aims to demonstrate that VR can effectively reduce perioperative anxiety and pain, leading to a lower requirement for sedatives and analgesics. By providing a non-pharmacological method to manage anxiety and pain, VR could improve the overall surgical experience for pediatric patients and enhance recovery outcomes. Additionally, the study seeks to validate the feasibility and acceptability of VR as a standard practice in pediatric surgical settings.

**Study Timeline**

The study is expected to last 24 months, including patient enrollment, data collection, and analysis. Each participant will be involved from the preoperative visit through the first 24 hours post-surgery. The results will be analyzed and published to contribute to the growing body of evidence supporting the use of VR in medical procedures.

**Ethical Considerations**

The study will be conducted following the principles of the Declaration of Helsinki and Good Clinical Practice (GCP) guidelines. Informed consent will be obtained from all participants and their parents or guardians. The privacy and confidentiality of all participants will be strictly maintained.

This study has the potential to revolutionize the approach to managing perioperative anxiety and pain in pediatric patients, offering a safe, effective, and enjoyable alternative to traditional sedative medications.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bologna, Italy
        • Recruiting
        • Istituto Ortopedico Rizzoli
        • Contact:
        • Principal Investigator:
          • Lesley de Pietri

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Children aged 7 to 12 years.
  • Scheduled for minor orthopedic surgery with a duration of less than 60 minutes.
  • Eligible for regional anesthesia.
  • Able to understand and cooperate with the study procedures.
  • Consent from both the child and their parent or legal guardian.

Exclusion Criteria:

  • Facial trauma that prevents the use of VR headsets.
  • Blindness or significant visual impairment.
  • Deafness or significant hearing impairment.
  • Cognitive impairments or intellectual disabilities.
  • Inability to understand the language used in the VR content.
  • Poor fit of the VR headset on the child's face.
  • Inability to understand Italian.
  • Current use of analgesics or sedatives at home.
  • Certified psychiatric diagnosis.
  • Epilepsy or history of seizures.
  • Recent head trauma, severe headaches, or vertigo.
  • Any condition deemed by the anesthesiologist to be unsafe for VR use.
  • Failure to properly apply topical anesthetics before invasive procedures.
  • Allergy to local anesthetics.
  • Surgery duration expected to exceed 60 minutes.
  • Anticipated need for general anesthesia or deep sedation requiring advanced airway management.
  • Predicted difficult venous access (DIVA)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control
pre-surgery sedation
Experimental: VR
virtual reality sedation
pre-surgery sedation using virtual reality headset

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
anxiety level
Time Frame: 24 hours
level of anxiety with cam-s
24 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
hormons levels
Time Frame: preoperative
levels of stress hormons
preoperative
pain level
Time Frame: 24 hours
difference in pain levels
24 hours
compliance during induction
Time Frame: during induction
compliance during induction of anesthesia with micc
during induction
drugs dosage
Time Frame: intraoperative
dosage of drugs necessary for induction of anesthesia
intraoperative
surgeons satisfaction
Time Frame: immediately after the intervention
general satisfaction of the surgeons from 1 to 10
immediately after the intervention
parents satisfaction
Time Frame: immediately after the intervention
general satisfaction of the parents from 1 to 10
immediately after the intervention
or time occupation
Time Frame: intraoperative
time of occupation of the or
intraoperative
adverse event
Time Frame: 24 hours
adverse avent using virtual reality
24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 3, 2024

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 3, 2026

Study Registration Dates

First Submitted

September 10, 2024

First Submitted That Met QC Criteria

September 17, 2024

First Posted (Actual)

September 19, 2024

Study Record Updates

Last Update Posted (Actual)

February 18, 2026

Last Update Submitted That Met QC Criteria

February 17, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 211/2024/DISP/IOR

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Virtual Reality

Clinical Trials on hypno VR

Subscribe